XML 60 R46.htm IDEA: XBRL DOCUMENT v3.22.0.1
STOCK-BASED COMPENSATION (Tables)
12 Months Ended
Dec. 31, 2021
Share-based Payment Arrangement [Abstract]  
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions
The following table presents the weighted-average grant date fair value of options granted for the periods presented and the assumptions used to estimate those values using a Black-Scholes option pricing model.
Years Ended December 31,
202120202019
Weighted average grant date fair value**$38.45$9.16
Expected term (in years)**3.83.8
Expected volatility**86.4%89.1%
Annual risk-free rate of return**0.1%2.1%
Dividend yield**—%—%
**    No stock options were granted during the year ended December 31, 2021.
Summary of the Components of Total Stock-Based Compensation Expense The following table summarizes the components of total stock-based compensation expense included in the consolidated statements of operations for the periods presented.
Years Ended December 31,
202120202019
(In thousands)
Cost of revenues$7,366 $3,759 $1,650 
Research and development33,927 12,701 4,897 
Sales and marketing37,434 11,548 5,678 
General and administrative35,559 14,495 7,216 
Restructuring— — 735 
Total$114,286 $42,503 $20,176 
Income tax benefit included in the provision for incomes taxes$97,129 $61,389 $8,185 
Summary of Stock-Based Compensation Associated with Each Type of Award
The following table summarizes the various types of stock-based compensation expense for the periods presented.
Years Ended December 31,
202120202019
(In thousands)
Stock options, RSUs and PSUs$110,142 $39,841 $19,216 
Employee stock purchase plan4,144 2,662 960 
Total$114,286 $42,503 $20,176 
Summary of Stock Option Activity
The following is a summary of stock option activity.
Number of
Shares
Outstanding
Weighted-
Average
Exercise Price
per Share
Weighted-
Average
Remaining
Contractual
Term
Aggregate
Intrinsic
Value
(1)
(In thousands)(Years)(In thousands)
Outstanding at December 31, 20186,772 $1.76 
Granted43 14.58 
Exercised(2,616)1.22 $31,093 
Canceled(102)4.07 
Outstanding at December 31, 20194,097 $2.18 
Granted11 64.17 
Exercised(1,494)2.74 $114,089 
Canceled(82)6.94 
Outstanding at December 31, 20202,532 $1.96 
Granted— — 
Exercised(267)2.44 $42,091 
Canceled(1)0.83 
Outstanding at December 31, 20212,264 $1.90 2.8$409,834 
Vested and expected to vest at December 31, 20212,264 $1.90 2.8$409,834 
Exercisable at December 31, 20212,262 $1.90 2.8$409,550 
(1)    The intrinsic value of options exercised is based upon the value of the Company’s stock at exercise. The intrinsic value of options outstanding, vested and expected to vest, and exercisable as of December 31, 2021 is based on the closing price of the last trading day during the period ended December 31, 2021. The Company’s stock fair value used in this computation was $182.94 per share.
Summary of Stock Option Outstanding
The following table summarizes information about stock options outstanding at December 31, 2021.
Options OutstandingOptions Exercisable
Range of Exercise PricesNumber of
Shares
Weighted-
Average
Remaining
Life
Weighted-
Average
Exercise
Price
Number of
Shares
Weighted-
Average
Exercise
Price
(In thousands)(Years)(In thousands)
$0.70 —– $1.11
486 3.3$0.86 486 $0.85 
$1.29 —– $1.29
1,000 2.71.29 1,000 1.28 
$1.31 —– $1.31
556 2.31.31 556 1.31 
$1.53 —– $14.58
211 3.15.65 209 5.65 
$64.17 —– $64.17
11 5.464.17 11 64.17 
Total2,264 2.8$1.90 2,262 $1.90 
Summary of Restricted Stock Unit Activity
The following is a summary of RSU activity.
Number of
Shares
Outstanding
Weighted-
Average
Fair Value
per Share at
Grant Date
Weighted-
Average
Remaining
Contractual
Term
Aggregate
Intrinsic
Value
(1)
(In thousands)(Years)(In thousands)
Outstanding at December 31, 20184,352 $3.52 
Granted2,112 11.50 
Vested(1,707)3.87 $27,156 
Canceled(494)4.81 
Outstanding at December 31, 20194,263 $7.19 
Granted1,550 55.66 
Vested(2,085)7.26 $125,578 
Canceled(140)19.47 
Outstanding at December 31, 20203,588 $27.61 
Granted1,301 179.88 
Vested(1,979)20.47 $364,665 
Canceled(124)88.50 
Outstanding at December 31, 20212,786 $100.73 1.2$509,864 
Expected to vest at December 31, 20212,786 $100.73 1.2$509,864 
(1)    The intrinsic value of RSUs vested is based upon the value of the Company’s stock when vested. The intrinsic value of RSUs outstanding and expected to vest as of December 31, 2021 is based on the closing price of the last trading day during the period ended December 31, 2021. The Company’s stock fair value used in this computation was $182.94 per share.
Share-based Compensation, Performance Shares Award Outstanding Activity
The following is a summary of PSU activity.
Number of
Shares
Outstanding
Weighted-
Average
Fair Value
per Share at
Grant Date
Weighted-
Average
Remaining
Contractual
Term
Aggregate
Intrinsic
Value
(1)
(In thousands)(Years)(In thousands)
Outstanding at December 31, 20181,330 $4.66 
Granted1,052 9.48 
Vested(1,063)4.62 $10,818 
Canceled(364)5.16 
Outstanding at December 31, 2019955 $9.83 
Granted989 31.12 
Vested(1,450)10.20 $52,144 
Canceled— — 
Outstanding at December 31, 2020494 $51.10 
Granted715 131.60 
Vested(494)59.19 $91,803 
Canceled(270)52.75 
Outstanding at December 31, 2021445 $169.82 0.2$81,456 
(1)    The intrinsic value of PSUs vested is based upon the value of the Company’s stock when vested. The intrinsic value of PSUs outstanding and expected to vest as of December 31, 2021 is based on the closing price of the last trading day during the period ended December 31, 2021. The Company’s stock fair value used in this computation was $182.94 per share.
Schedule of Share-based Compensation, Employee Stock Purchase Plan, Activity
A summary of ESPP activity for the years presented is as follows: (in thousands, except per share data):
Years Ended December 31,
202120202019
Proceeds from common stock issued under ESPP$6,832 $4,304 $1,692 
Shares of common stock issued235 347 315 
Weighted-average price per share$29.12 $12.41 $5.37